NIH study finds two doses of HPV vaccine may be as protective as full course

NIH study finds two doses of HPV vaccine may be as protective as full course

   September 14, 2011       SNap(R)

---

NIH Radio Update for today: You are subscribed to NIH Radio Audio Reports for National Institutes of Health (NIH). This information has recently been updated and is now available at http://www.nih.gov/news/radio/radio.htm.  NIH study finds two doses of HPV vaccine may be as protective as full course 09/13/2011 10:05 AM EDT   Two doses of the human papillomavirus (HPV) vaccine Cervarix are as effective as the current standard three-dose regimen after four years of follow-up according to the results of a community-based clinical trial on Cervarix in Costa Rica. Transcript This service is provided to you by the National Institutes of Health — Turning Discovery Into Health. NIH... Turning Discovery Into Health is a trademark of the U.S. Department of Health and Human Services.